Reduction of the Side Effects during Chemotherapy by Amino Acids
Phase 4
- Conditions
- Gastrointestinal disease
- Registration Number
- JPRN-UMIN000028378
- Lead Sponsor
- Hamamatsu Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. History or present usage of Cytine and Theanine supplementation. 2. Patinets with severe metabolic disease (ex. uncontrolled diabetes, refractory cachexia or respiratory failure). 3. Patients with swallowing disturbance. 4. Physisians decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Verification of improve rates after one month of supplementation
- Secondary Outcome Measures
Name Time Method